Strategic Wealth Investment Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $1.59M | Sell |
17,849
-752
| -4% | -$67.1K | 0.24% | 55 |
|
|
2023
Q3 | $1.36M | Sell |
18,601
-344
| -2% | -$25.1K | 0.25% | 53 |
|
|
2023
Q2 | $1.58M | Sell |
18,945
-5,784
| -23% | -$481K | 0.25% | 63 |
|
|
2023
Q1 | $1.88M | Buy |
24,729
+3,978
| +19% | +$303K | 0.35% | 56 |
|
|
2022
Q4 | $1.78M | Buy |
20,751
+95
| +0.5% | +$8.15K | 0.41% | 52 |
|
|
2022
Q3 | $1.64M | Buy |
20,656
+3,998
| +24% | +$317K | 0.47% | 48 |
|
|
2022
Q2 | $1.24M | Buy |
16,658
+2,262
| +16% | +$168K | 0.31% | 68 |
|
|
2022
Q1 | $1.29M | Buy |
14,396
+4,016
| +39% | +$361K | 0.31% | 48 |
|
|
2021
Q4 | $1.16M | Buy |
10,380
+804
| +8% | +$90K | 0.3% | 50 |
|
|
2021
Q3 | $1.22M | Buy |
9,576
+1,889
| +25% | +$241K | 0.37% | 47 |
|
|
2021
Q2 | $1.04M | Buy |
7,687
+2,284
| +42% | +$309K | 0.37% | 44 |
|
|
2021
Q1 | $733K | Buy |
5,403
+440
| +9% | +$59.7K | 0.35% | 47 |
|
|
2020
Q4 | $699K | Buy |
4,963
+383
| +8% | +$53.9K | 0.41% | 49 |
|
|
2020
Q3 | $510K | Buy |
4,580
+484
| +12% | +$53.9K | 0.38% | 55 |
|
|
2020
Q2 | $459K | Buy |
+4,096
| New | +$459K | 0.45% | 53 |
|